review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1515/CCLM.2000.128 |
P698 | PubMed publication ID | 11097344 |
P2093 | author name string | F F Kadlubar | |
G McClure | |||
S L MacLeod | |||
S Nowell | |||
J Plaxco | |||
J Massengill | |||
A Jazieh | |||
N P Lan | |||
P2860 | cites work | Human liver microsomal metabolism of paclitaxel and drug interactions | Q28610020 |
Clinical pharmacokinetics of docetaxel. | Q30657347 | ||
Modulation of P450-dependent ifosfamide pharmacokinetics: a better understanding of drug activation in vivo | Q34749403 | ||
Human cytochromes P450: problems and prospects | Q35856204 | ||
Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes | Q37362341 | ||
CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity | Q38315596 | ||
Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. | Q44686949 | ||
P433 | issue | 9 | |
P304 | page(s) | 883-887 | |
P577 | publication date | 2000-09-01 | |
P1433 | published in | Clinical Chemistry and Laboratory Medicine | Q5133754 |
P1476 | title | Cancer therapy and polymorphisms of cytochromes P450. | |
P478 | volume | 38 |
Q37156427 | Differences in hematotoxicity between male and female patients with Hodgkin lymphoma and other malignancies |
Q34606802 | Effect of the cytochrome P450 2C19 inhibitor omeprazole on the pharmacokinetics and safety profile of bortezomib in patients with advanced solid tumours, non-Hodgkin's lymphoma or multiple myeloma |
Q40560358 | In vitro characterization of the biotransformation of thiocoraline, a novel marine anti-cancer drug |
Q40288530 | In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug |
Q36271954 | Modulation of oral drug bioavailability: from preclinical mechanism to therapeutic application |
Q36221957 | Personalised medicine for cancer: from drug development into clinical practice |
Q36097229 | Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism |
Q44654810 | The impact of current tobacco use on the outcome of paracetamol poisoning |
Q64240769 | Tumor response to irinotecan is associated with CYP3A5 expression in colorectal cancer |
Search more.